Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsMedical Oncology & ChemotherapyCancer-Associated Thrombosis (CAT): Direct Oral Anticoagulants (DOACs) vs. LMWH in High-Risk Malignancies
Medical Oncology & Chemotherapy

Cancer-Associated Thrombosis (CAT): Direct Oral Anticoagulants (DOACs) vs. LMWH in High-Risk Malignancies

10 min read
Sep 10, 2026
Spica Healthcare Clinical & Surgical Protocol Illustration #118

Clinical Summary & Key Takeaways

An indispensable clinical hematologic oncology guide on managing Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in cancer patients, evaluating the Khorana Risk Score, Direct Oral Anticoagulants (Apixaban, Rivaroxaban, Edoxaban) vs. LMWH, and GI mucosal bleeding precautions.

CRITICAL CLINICAL RED FLAG: Sudden onset of unilateral leg swelling and calf tenderness (DVT) or acute unexplained shortness of breath, pleuritic chest pain, and tachycardia (PE) in an active oncology patient demands emergency venous Doppler ultrasound or CT Pulmonary Angiography.

1. The Prothrombotic State in Malignancy

Malignant neoplasms generate a continuous hypercoagulable state through tumor expression of tissue factor, release of procoagulant microparticles, production of inflammatory cytokines (TNF-alpha, IL-1), and vascular stasis from extrinsic venous compression. Cancer patients face a 4- to 7-fold elevated risk of venous thromboembolism compared to non-cancer populations.

  • High-Risk Tumor Types: Pancreatic, stomach, brain, lung, ovarian, and hematologic malignancies.

  • Treatment Factors: Chemotherapy (Cisplatin, Thalidomide/Lenalidomide), central venous catheters, and major pelvic/abdominal surgery.

2. The Khorana Risk Score: Stratifying Thrombosis Risk

Calculated prior to starting systemic chemotherapy:

  1. Very High Risk Site (Pancreas, Stomach): 2 points.

  2. High Risk Site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): 1 point.

  3. Pre-chemotherapy Platelet Count >=350,000/mcL: 1 point.

  4. Hemoglobin <10 g/dL or use of ESA: 1 point.

  5. Pre-chemotherapy Leukocyte Count >11,000/mcL: 1 point.

  6. BMI >=35 kg/m²: 1 point. (Score >=2 qualifies for thromboprophylaxis consideration).

"Venous thromboembolism is the second leading cause of mortality in cancer patients. Early risk scoring and tailored DOAC anticoagulation save lives without compromising ongoing cancer treatment." — Dr. Neha Gupta
Spica Healthcare Clinical & Surgical Protocol Illustration #118
Spica Healthcare Clinical & Surgical Protocol Illustration #118

3. DOACs vs. LMWH: The CARAVAGGIO & SELECT-D Evidence

Oral Factor Xa inhibitors (Apixaban 10 mg BID x7 days followed by 5 mg BID; Rivaroxaban 15 mg BID x21 days followed by 20 mg OD) demonstrate non-inferior efficacy compared to subcutaneous Dalteparin with superior patient convenience and quality of life.

CLINICAL CAUTION: Direct Oral Anticoagulants (DOACs) carry an elevated risk of major gastrointestinal bleeding in patients with active, unresected luminal GI malignancies (gastric, esophageal, or colorectal cancers); Low Molecular Weight Heparin (LMWH) is preferred in these cases.

4. Duration of Anticoagulation: Minimum 6 Months and Beyond

Anticoagulation must be maintained for a minimum of 6 months and continued indefinitely as long as active cancer or ongoing systemic antineoplastic therapy persists.

5. Peer-Reviewed References & Clinical Guidelines

1. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer (CARAVAGGIO Trial) — NEJM, 2020; 382: 1599-1607.

2. Management of Cancer-Associated Thrombosis: ASCO Clinical Practice Guideline Update — J Clin Oncol, 2023; 41(20): 3672-3691.

Frequently Asked Patient Questions

Yes. Over 85% of modern systemic cancer protocols are delivered safely in dedicated outpatient daycare infusion suites with continuous electronic vitals monitoring, allowing patients to sleep in their own beds at home the same night.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Senior Consultant & Clinical Director — Medical Oncology

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.